Phyton Biotech
upstream
Upstream Capabilities

upstreamWe provide our partners a unique package for commercial manufacturing and development of Active Ingredients via plant cell fermentation and other expression systems.

Large Scale Fermentation

  • 880.000 L/year production capacity for taxanes
  • HPAPI handling
  • cGMP compliant process
  • Fermentation trains
    • 2 prefermentation areas (one BSL 1 classified)
    • 9 fermenters 55 L to 75.000 L
    • 4 fermenters 75 L to 7.500 L (BSL 1 classified)
    • Strain bank storage

Process Development

  • 12 parallel 16 L fermenters (in BSL 1 area)
  • Multiple incubator cabinets for shake flask cultivations
  • Miniaturized cultivation systems in well plate format for screening experiments
  • Cryopreservation and cell bank operation
  • Product isolation and purification (resin adsorption, biomass separation, static and dynamic filtration processes)

GMP compliant Analytics and Quality Control

  • Comprehensive set of optimised IPCs
  • Analytical method development
  • Production control experiments

Markets

  • Pharmaceuticals
  • Cosmeceuticals
  • Nutraceuticals
  • Biopharmaceuticals